Position in IOVA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$8,777,188
+$583,090 QoQ
Shares Held
2,500,624
-16.7% QoQ
Ownership
0.560%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88.67226740205645.ToString("F0")%
Shared 0.ToString("F0")%
None 11.327732597943553.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. IOVA ranks #79 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in IOVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,777,188 | 2,500,624 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,194,098 | 3,001,502 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,655,711 | 1,223,831 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $2,137,736 | 1,242,871 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,263,230 | 1,280,250 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,670,511 | 1,306,826 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $17,774,629 | 1,892,932 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $27,574,617 | 3,438,232 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $64,995,982 | 4,385,694 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $23,086,490 | 2,839,667 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $12,495,918 | 2,746,356 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $18,552,419 | 2,635,287 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $12,643,855 | 2,069,371 | Shares | Other | 2023-05-18 | |
| 2022-12-31 | $14,927,805 | 2,336,120 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $20,245,201 | 2,113,278 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $22,540,024 | 2,041,669 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $30,864,653 | 1,853,733 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $38,512,756 | 2,017,431 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $40,411,228 | 1,638,736 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $36,818,479 | 1,415,007 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $42,513,332 | 1,342,809 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $43,755,802 | 943,013 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $23,158,298 | 703,472 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $17,194,103 | 626,379 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $16,711,219 | 558,157 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||